GC
IMMU

Grimes & Company’s Immunomedics Inc IMMU Stock Holding History

Grimes & Company’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-4,150
Closed -$353K – 273
2020
Q3 		$353K Sell
4,150
-2,610
-39% -$132K 0.02% 201
2020
Q2 		$240K Buy
+6,760
New +$198K 0.02% 223

Grimes & Company's IMMU Position: Q4 2020 in Review

Grimes & Company sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 4,150 shares — an estimated $353K sold.

Grimes & Company first reported a position in IMMU in Q2 2020 and held it in 2 quarters. The position peaked at $353K in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

  • Grimes & Company reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
  • Grimes & Company sold 4,150 Immunomedics Inc shares in Q4 2020, an estimated $353K.
  • Grimes & Company first reported a position in Immunomedics Inc in Q2 2020 and held it in 2 quarters.
  • Grimes & Company's Immunomedics Inc position peaked at $353K in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on Grimes & Company's 13F filing for Q4 2020, filed 2 Feb 2021.